To determine whether HDAC2 promotes HCC malignancy by facilitating autophagy, we administered the autophagy inhibitor 3-methyladenine (3-MA) to HDAC2-overexpressing cells. This evidence concerns the gene HDAC2 and hepatocellular carcinoma.